Bristol-Myers adds three directors in deal with JANA Partners

Feb 21 (Reuters) - Bristol-Myers Squibb Co said on Tuesday it appointed three directors to its board in a deal with JANA Partners LLC, an activist investor holding less than 1 percent of the company's stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.